These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26551407)

  • 41. Polyunsaturated fatty acid supplementation for ADHD symptoms: response to commentary.
    Sinn N
    J Dev Behav Pediatr; 2007 Jun; 28(3):262-3. PubMed ID: 17565297
    [No Abstract]   [Full Text] [Related]  

  • 42. The Role of Nutritional Supplements in the Treatment of ADHD: What the Evidence Says.
    Lange KW; Hauser J; Lange KM; Makulska-Gertruda E; Nakamura Y; Reissmann A; Sakaue Y; Takano T; Takeuchi Y
    Curr Psychiatry Rep; 2017 Feb; 19(2):8. PubMed ID: 28168597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of nutritional interventions on the functioning of children with ADHD and/or ASD. An updated review of research evidence.
    Martí LF
    Bol Asoc Med P R; 2010; 102(4):31-42. PubMed ID: 21766545
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of Pharmacotherapy.
    Childress AC; Sallee FR
    CNS Drugs; 2015 Aug; 29(8):683-93. PubMed ID: 26267739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nutritional supplements for the treatment of ADHD.
    Bloch MH; Mulqueen J
    Child Adolesc Psychiatr Clin N Am; 2014 Oct; 23(4):883-97. PubMed ID: 25220092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Marine Omega-3 Fatty Acid Supplementation for Borderline Personality Disorder: A Meta-Analysis.
    Karaszewska DM; Ingenhoven T; Mocking RJT
    J Clin Psychiatry; 2021 May; 82(3):. PubMed ID: 34004088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Omega-3 polyunsaturated fatty acids and reduction of depressive symptoms in older adults: A systematic review and meta-analysis.
    Bai ZG; Bo A; Wu SJ; Gai QY; Chi I
    J Affect Disord; 2018 Dec; 241():241-248. PubMed ID: 30138808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Omega-3 Polyunsaturated Fatty Acid Supplementation for Reducing Muscle Soreness after Eccentric Exercise: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Lv ZT; Zhang JM; Zhu WT
    Biomed Res Int; 2020; 2020():8062017. PubMed ID: 32382573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physical fatty acid deficiency signs in children with ADHD symptoms.
    Sinn N
    Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):109-15. PubMed ID: 17825546
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biochemical and Psychological Effects of Omega-3/6 Supplements in Male Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Clinical Trial.
    Matsudaira T; Gow RV; Kelly J; Murphy C; Potts L; Sumich A; Ghebremeskel K; Crawford MA; Taylor E
    J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):775-82. PubMed ID: 26682998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD.
    Sinn N; Bryan J
    J Dev Behav Pediatr; 2007 Apr; 28(2):82-91. PubMed ID: 17435458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comorbid symptom severity in attention-deficit/hyperactivity disorder: a clinical study.
    Connor DF; Ford JD
    J Clin Psychiatry; 2012 May; 73(5):711-7. PubMed ID: 22697195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials.
    Sadeghi A; Djafarian K; Mohammadi H; Shab-Bidar S
    Diabetes Metab Syndr; 2017; 11(2):157-162. PubMed ID: 27484441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Attention-deficit hyperactivity disorder and children's emotion dysregulation: A meta-analysis.
    Graziano PA; Garcia A
    Clin Psychol Rev; 2016 Jun; 46():106-23. PubMed ID: 27180913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials.
    Liu T; Korantzopoulos P; Shehata M; Li G; Wang X; Kaul S
    Heart; 2011 Jul; 97(13):1034-40. PubMed ID: 21478384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Emotion dysregulation in adults with attention deficit hyperactivity disorder: a meta-analysis.
    Beheshti A; Chavanon ML; Christiansen H
    BMC Psychiatry; 2020 Mar; 20(1):120. PubMed ID: 32164655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial.
    Milte CM; Parletta N; Buckley JD; Coates AM; Young RM; Howe PR
    Nutrition; 2012 Jun; 28(6):670-7. PubMed ID: 22541055
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Omega-3 fatty acids are inversely related to callous and unemotional traits in adolescent boys with attention deficit hyperactivity disorder.
    Gow RV; Vallee-Tourangeau F; Crawford MA; Taylor E; Ghebremeskel K; Bueno AA; Hibbeln JR; Sumich A; Rubia K
    Prostaglandins Leukot Essent Fatty Acids; 2013 Jun; 88(6):411-8. PubMed ID: 23664595
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Omega-3 fatty acids, part I: the effects of n-3 polyunsaturated fatty acid in the treatment of attention-deficit hyperactivity disorder in children.
    Ross SM
    Holist Nurs Pract; 2012; 26(6):356-9. PubMed ID: 23075752
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of Methylphenidate on Emotional Dysregulation in Children With Attention-Deficit/Hyperactivity Disorder + Oppositional Defiant Disorder/Conduct Disorder.
    Kutlu A; Akyol Ardic U; Ercan ES
    J Clin Psychopharmacol; 2017 Apr; 37(2):220-225. PubMed ID: 28225747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.